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To the Editor: In her article on pediatric hyper-
tension, Ingelfinger does not mention the role of 
uric acid and hyperuricemia. Randomized trials 
have shown the benefits of urate-lowering treat-
ment in lowering blood pressure in adolescents 
with hyperuricemia and recently diagnosed es-
sential hypertension1 and in obese adolescents 
with prehypertension.2 I believe that there is suf-
ficient evidence to support the inclusion of uric 
acid measurement in the workup for evaluation 
of adolescents with suspected hypertension and 
for a trial of allopurinol in those with hyperuri-
cemia.
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The author replies: Gupta and Gupta point out 
the importance of sleep-disordered breathing in 
the pathobiology of adolescent hypertension, 
though sleep patterns were among the factors 
mentioned in the article as part of the medical 
evaluation and nonpharmacologic therapy. In ad-
dition to their study,1 work from the Tucson Chil-
dren’s Assessment of Sleep Apnea Study has indi-
cated that decreased sleep time and elevated 
body-mass index are associated with increases in 
blood-pressure levels.2 Best therapy for sleep-
disordered breathing in children and adolescents 
is an evolving area, especially because adherence 
to CPAP regimens is difficult for children and 
adolescents, as discussed in a recent review by 
Tapia and Marcus.3
Uric acid, as Bellomo notes, has been evalu-
ated as a biomarker for essential hypertension in 
children and adolescents. Much data, particu-
larly from animal models, indicate that increas-
es in uric acid lead first to reversible vasocon-
strictive changes, mediated by stimulation of 
renin release and a decrease in the levels of cir-
culating nitrates, and later to a second phase in 
which changes in the vasculature within the 
kidney result in sustained blood-pressure eleva-
tion and, ultimately, to salt-sensitive hyperten-
sion.4 Currently, short-term data indicate that 
the use of allopurinol in children or adolescents 
with hypertension may be effective, but such 
studies are preliminary.4 Further and longer-
term trials would be needed before allopurinol 
or other therapy to lower uric acid levels in chil-
dren with hypertension would be recommended.
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Pregnancy and Infection
To the Editor: Kourtis and colleagues (June 5 
issue)1 describe the effect of pregnancy on the 
susceptibility to and severity of infections, but 
they only briefly mention the human immunode-
ficiency virus (HIV). This is surprising, given 
that HIV causes up to 25% of deaths during preg-
nancy and the postpartum period in women in 
sub-Saharan Africa.2 Rigorous studies on the in-
teraction between pregnancy and HIV are scarce, 
but most of the available data suggest that preg-
The New England Journal of Medicine 
Downloaded from nejm.org on October 5, 2017. For personal use only. No other uses without permission. 
 Copyright © 2014 Massachusetts Medical Society. All rights reserved. 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 371;11 nejm.org september 11, 20141076
nancy does not increase HIV acquisition3 or the 
severity of HIV-related illness. In addition, HIV 
does not increase the risk of obstetrical compli-
cations, with the exception of sepsis.4 Whether 
pregnancy accelerates HIV disease progression is 
uncertain. Pregnant women tend to have less ad-
vanced HIV disease than nonpregnant women, 
but few studies stratify patients according to the 
stage of HIV infection at the start of follow-up. A 
study involving HIV-infected women who were 
receiving antiretroviral therapy did not show that 
pregnancy was associated with an increased risk 
of death.5 This finding implies that the HIV-
attributable mortality among pregnant women is 
largely coincidental to pregnancy, and there is little 
reason to discourage healthy HIV-infected women 
who want to become pregnant from doing so.
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To the Editor: Kourtis et al. review specific in-
fections in pregnancy and the available scant evi-
dence of the increased severity of and suscepti-
bility to infections among pregnant women. 
However, they omit infections caused by two im-
portant pathogens that adversely affect the health 
and treatment outcomes of mothers and children 
worldwide: Mycobacterium tuberculosis and cyto-
megalovirus (CMV).
Globally, tuberculosis causes an estimated 
half-million deaths per year in women, a large 
proportion of whom are of reproductive age. 
Although this condition remains underdiagnosed 
in pregnant women, the incidence of tuberculo-
sis, tuberculosis-associated mortality, and the 
risk of hospitalization are high among pregnant 
women.1 Clinical observations show that preg-
nancy may have an effect on the pathogenesis of 
tuberculosis and increases the maternal risk of 
M. tuberculosis infection or reactivation of latent 
tuberculosis.2,3
CMV infection is one of the most common 
viral infections in humans and can remain latent 
and reactivate under conditions of immunosup-
pression.4 CMV infections can reactivate in preg-
nant women and be transmitted to the neonate 
in utero or through breast milk.
The complex relationships between pregnancy-
induced immunologic changes and infection with 
intracellular pathogens remain to be defined 
through carefully designed case-controlled studies.
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To the Editor: The review article by Kourtis et 
al. focuses on the increased seriousness of a 
number of viral disorders, malaria, coccidioido-
mycosis, and a single bacterial disorder, listerio-
sis, during gestation. However, perhaps the most 
prevalent example of infection-related virulence 
in pregnancy is the response to severe urinary 
tract infection and urosepsis. An important part 
of prenatal care is screening to detect bacteriuria 
in early pregnancy, and the literature shows that 
asymptomatic bacteria left untreated can be fol-
lowed by acute pyelonephritis in about a fourth 
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of women in whom bacteriuria is present.1 More-
over, as compared with complications in non-
pregnant women, this infection in pregnant 
women can be quite virulent and can be associ-
ated with both substantial decreases in the glo-
merular filtration rate and volume-independent 
permeability pulmonary edema, which is virtu-
ally absent in nonpregnant women.2,3
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The Authors Reply: We agree with Calvert and 
Ronsmans that the evidence regarding increased 
susceptibility to HIV infection during pregnancy, 
although intriguing, remains inconclusive.1 We 
also agree that data are lacking to indicate in-
creased severity of HIV infection among preg-
nant women, and most of the existing data, al-
though imperfect, do not suggest acceleration of 
HIV disease during pregnancy.1 
Most of the literature on increased severity of 
tuberculosis during pregnancy dates from the 
pre-antibiotic era, and rigorously conducted stud-
ies regarding this question in the era of chemo-
therapy for tuberculosis are scarce. A recent large 
cohort study involving pregnant women in the 
United Kingdom showed no increase in the inci-
dence of tuberculosis during pregnancy, but it 
did show an increased risk during the first 
6 months post partum.2 We agree with Zumla 
et al. that well-designed studies to address this 
question are needed.
Despite the well-recognized and potentially 
serious outcomes of CMV infection in neonates, 
data are lacking to support the increased risk of 
CMV acquisition or CMV severity among preg-
nant women. Finally, although potentially serious 
urinary tract infections and pyelonephritis are 
more common in pregnant women than in non-
pregnant women, these risks are largely attribut-
able to mechanical and physiological factors.
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Medicare Readmission Penalties in Detroit
To the Editor: In 2013, more than 2200 U.S. 
hospitals forfeited a total of approximately $280 
million in Medicare funds because their readmis-
sion rates for congestive heart failure, pneumo-
nia, and acute myocardial infarction exceeded 
expected rates; these readmission penalties were 
stipulated by the Affordable Care Act.1 We evalu-
ated 2013 and 2014 readmission penalties levied 
against hospitals in Detroit, as compared with 
penalties assessed against hospitals in other 
large cities in the East North Central region of 
the United States (as defined by the U.S. Census), 
and we correlated this information with census-
derived socioeconomic data.2 We also compared 
readmission penalties for hospitals in the large 
cities with penalties for hospitals in the remain-
der of the respective state.
With regard to the largest metropolitan areas 
in each of the five states in the East North Cen-
tral region, hospitals in Detroit had the highest 
mean readmission penalties in 2013 (0.93±0.13% 
of Medicare payments, P<0.05 for the compari-
sons with the other metropolitan areas) and in 
2014 (0.86±0.19%, P<0.05 for the comparisons 
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